Heparin in stroke: not for most, but the controversy lingers.

Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9459

Full metadata record

DC Field	Value	Language
dc.contributor.author	Donnan, Geoffrey A	en
dc.contributor.author	Davis, Stephen M	en
dc.date.accessioned	2015-05-15T22:33:46Z
dc.date.available	2015-05-15T22:33:46Z
dc.date.issued	2003-01-01	en
dc.identifier.citation	Stroke; A Journal of Cerebral Circulation; 34(1): 232-3	en
dc.identifier.govdoc	12511781	en
dc.identifier.other	PUBMED	en
dc.identifier.uri	https://ahro.austin.org.au/austinjspui/handle/1/9459	en
dc.language.iso	en	en
dc.subject.other	Anticoagulants.adverse effects.therapeutic use	en
dc.subject.other	Brain Ischemia.drug therapy	en
dc.subject.other	Heparin.adverse effects.therapeutic use	en
dc.subject.other	Humans	en
dc.subject.other	Stroke.drug therapy	en
dc.title	Heparin in stroke: not for most, but the controversy lingers.	en
dc.type	Journal Article	en
dc.identifier.journaltitle	Stroke	en
dc.identifier.affiliation	National Stroke Research Institute, Austin and Repatriation Medical Center and the University of Melbourne, Australia	en
dc.description.pages	232-3	en
dc.relation.url	https://pubmed.ncbi.nlm.nih.gov/12511781	en
dc.type.austin	Journal Article	en
local.name.researcher	Donnan, Geoffrey A
item.openairecristype	http://purl.org/coar/resource_type/c_18cf	-
item.openairetype	Journal Article	-
item.grantfulltext	none	-
item.cerifentitytype	Publications	-
item.fulltext	No Fulltext	-
item.languageiso639-1	en	-
crisitem.author.dept	The Florey Institute of Neuroscience and Mental Health	-
Appears in Collections:	Journal articles

32

checked on Oct 4, 2024

Check